X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27803) 27803
Newsletter (708) 708
Magazine Article (83) 83
Book Chapter (79) 79
Newspaper Article (65) 65
Dissertation (56) 56
Web Resource (14) 14
Journal / eJournal (11) 11
Publication (8) 8
Conference Proceeding (5) 5
Book Review (4) 4
Book / eBook (2) 2
Report (2) 2
Streaming Video (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16804) 16804
amphotericin b (8572) 8572
male (8343) 8343
amphotericin b - therapeutic use (8187) 8187
amphotericin-b (7121) 7121
female (6617) 6617
antifungal agents - therapeutic use (6217) 6217
microbiology (5168) 5168
adult (5141) 5141
animals (4799) 4799
middle aged (4497) 4497
infectious diseases (4342) 4342
pharmacology & pharmacy (4254) 4254
amphotericin b - pharmacology (3983) 3983
antifungal agents - pharmacology (3794) 3794
amphotericin b - administration & dosage (3399) 3399
fluconazole (3081) 3081
antiparasitic agents (2630) 2630
microbial sensitivity tests (2629) 2629
aged (2606) 2606
voriconazole (2534) 2534
antifungal agents - administration & dosage (2356) 2356
candidiasis - drug therapy (2315) 2315
antifungal agents (2227) 2227
treatment outcome (2131) 2131
mycoses - drug therapy (2092) 2092
adolescent (2041) 2041
infections (2036) 2036
mycology (2025) 2025
immunology (1971) 1971
mice (1967) 1967
itraconazole (1960) 1960
liposomal amphotericin-b (1829) 1829
child (1828) 1828
aspergillosis - drug therapy (1615) 1615
aspergillosis (1601) 1601
therapy (1576) 1576
fungal-infections (1533) 1533
health aspects (1525) 1525
drug therapy, combination (1522) 1522
mycoses (1513) 1513
infection (1500) 1500
diagnosis (1394) 1394
research (1354) 1354
epidemiology (1323) 1323
amphotericin b - adverse effects (1307) 1307
in-vitro (1292) 1292
immunocompromised host (1265) 1265
candida - drug effects (1262) 1262
risk factors (1236) 1236
caspofungin (1230) 1230
fluconazole - therapeutic use (1227) 1227
liposomes (1210) 1210
medicine, general & internal (1208) 1208
care and treatment (1201) 1201
candida albicans - drug effects (1174) 1174
candidiasis (1166) 1166
fungi (1126) 1126
analysis (1113) 1113
child, preschool (1065) 1065
fungal infections (1059) 1059
susceptibility (1052) 1052
retrospective studies (1048) 1048
antifungal agents - adverse effects (1028) 1028
candida (1016) 1016
drug therapy (1011) 1011
transplantation (994) 994
invasive aspergillosis (983) 983
candidiasis - microbiology (982) 982
efficacy (954) 954
resistance (951) 951
visceral leishmaniasis (927) 927
candida-albicans (922) 922
research article (916) 916
triazoles - therapeutic use (910) 910
fluconazole - pharmacology (909) 909
pharmacokinetics (907) 907
flucytosine - therapeutic use (902) 902
toxicity (900) 900
mortality (899) 899
drugs (892) 892
echinocandins (888) 888
infant (883) 883
cryptococcosis - drug therapy (863) 863
mucormycosis (848) 848
aspergillus (845) 845
drug resistance, fungal (838) 838
lung diseases, fungal - drug therapy (838) 838
surgery (834) 834
time factors (828) 828
leishmaniasis, visceral - drug therapy (827) 827
candida albicans (823) 823
biochemistry & molecular biology (822) 822
meningitis (814) 814
oncology (801) 801
pediatrics (799) 799
dose-response relationship, drug (780) 780
hematology (770) 770
dermatology (768) 768
mycoses - microbiology (764) 764
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25744) 25744
French (857) 857
Spanish (611) 611
German (538) 538
Japanese (428) 428
Russian (258) 258
Portuguese (173) 173
Italian (127) 127
Chinese (102) 102
Turkish (65) 65
Polish (47) 47
Korean (41) 41
Dutch (32) 32
Czech (23) 23
Danish (16) 16
Hungarian (14) 14
Norwegian (13) 13
Persian (13) 13
Hebrew (9) 9
Swedish (7) 7
Romanian (6) 6
Finnish (4) 4
Serbian (3) 3
Ukrainian (3) 3
Croatian (2) 2
Lithuanian (2) 2
Slovak (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Indonesian (1) 1
Slovenian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 14, pp. 1291 - 1302
Journal Article
Journal of controlled release, ISSN 0168-3659, 2017, Volume 256, pp. 46 - 55
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2016, Volume 63, Issue 4, pp. e1 - e60
Journal Article
PLoS neglected tropical diseases, ISSN 1935-2735, 2017, Volume 11, Issue 12, p. e0006052
Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing... 
ABC-TRANSPORTER MRPA | CUTANEOUS LEISHMANIASIS | PROTOZOAN PARASITE LEISHMANIA | AMPHOTERICIN-B RESISTANCE | MILTEFOSINE RESISTANCE | ANTIMONY-RESISTANT | DONOVANI PROMASTIGOTES | GENE AMPLIFICATION | SODIUM STIBOGLUCONATE | VISCERAL LEISHMANIASIS | PARASITOLOGY | TROPICAL MEDICINE | Leishmaniasis - immunology | Leishmania donovani - drug effects | Humans | Amphotericin B - pharmacology | Leishmania donovani - pathogenicity | Leishmaniasis - drug therapy | Leishmaniasis, Cutaneous - drug therapy | Phosphorylcholine - analogs & derivatives | Antiprotozoal Agents - pharmacology | Leishmaniasis, Visceral - drug therapy | Molecular Epidemiology | Phosphorylcholine - pharmacology | Treatment Failure | Leishmania - drug effects | Leishmaniasis - parasitology | Leishmaniasis, Visceral - parasitology | Leishmania - pathogenicity | Amphotericin B - therapeutic use | Antiprotozoal Agents - therapeutic use | Drug Therapy, Combination | Drug Resistance | Leishmania - genetics | Phosphorylcholine - therapeutic use | Care and treatment | Usage | Analysis | Causes of | Research | Leishmaniasis | Drug therapy, Combination | Drug resistance | Epidemiology | Drugs | Epidemics | Laboratories | Biochemistry | Parasites | Immunity | Tropical diseases | 21st century | Acquired immune deficiency syndrome--AIDS | Parasitic diseases | Visceral leishmaniasis | Human immunodeficiency virus--HIV | Physiology | Immune system | Vector-borne diseases | Parasitology | Medicine | Miltefosine | Chemotherapy | Infectious diseases | Molecular modelling | Sodium | Amphotericin B | Mutation | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 11, pp. 1004 - 1017
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2018, Volume 62, Issue 3
AmBisome (LAmB), a liposomal formulation of amphotericin B (AmB), is a second-line treatment for the parasitic skin disease cutaneous leishmaniasis (CL).... 
Cutaneous leishmaniasis | Pharmacodynamics | Amphotericin B | Pharmacokinetics | pharmacodynamics | C57BL/6 MICE | MICROBIOLOGY | BIODISTRIBUTION | amphotericin B | MODEL | cutaneous leishmaniasis | LIPOSOMAL AMPHOTERICIN-B | BALB/C MICE | CANDIDA-ALBICANS | PULMONARY ASPERGILLOSIS |